NCT03309033View on ClinicalTrials.gov

Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study

Active, not recruitingOBSERVATIONAL

Enrollment

991

Participants

Timeline

Start Date

July 2, 2018

Primary Completion Date

February 28, 2026

Study Completion Date

February 28, 2026

Conditions

Human Papillomavirus InfectionHuman Papillomavirus-Related Malignant Neoplasm

Interventions

PROCEDURE

Biospecimen Collection

Undergo collection of blood samples

OTHER

Questionnaire Administration

Complete questionnaire

Trial Locations (1)

50101

Agencia Costarricense de Investigaciones Biomédicas (ACIB), Liberia

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH

NCT03309033 - Extended Follow-up of Women Who Received One, Two, and Three Doses of the HPV Vaccine in the Costa Rica Vaccine Trial (CVT), ESCUDDO-CVT Study | Biotech Hunter | Biotech Hunter